GB Sciences Inc (GBLX): Dilution from toxic financing? Lazaru...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Re: noahrobertjackson post# 3769

Friday, 04/28/2017 1:59:10 PM

Friday, April 28, 2017 1:59:10 PM

Keep Last Read

Replies (1) Next 10 Prev Next

Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/12/2024 09:39:05 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 10:07:34 PM
Form 424B3 - Prospectus [Rule 424(b)(3)] • Edgar (US Regulatory) • 10/10/2023 02:00:29 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/08/2023 08:15:33 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2023 06:31:48 PM
Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 08/02/2023 08:18:58 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 07/14/2023 08:12:47 PM
Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 06/30/2023 12:00:24 PM

InvestorsHub NewsWire

Only $200 per official company press release!